PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 165 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $227,000 | -67.9% | 1,944 | -35.2% | 0.07% | -74.5% |
| Q1 2015 | $708,000 | +6.9% | 3,000 | -14.3% | 0.26% | -16.5% |
| Q4 2014 | $662,000 | -30.6% | 3,500 | -12.5% | 0.31% | -34.7% |
| Q3 2014 | $954,000 | +261.4% | 4,000 | 0.0% | 0.48% | +161.0% |
| Q2 2014 | $264,000 | -59.1% | 4,000 | -35.5% | 0.18% | -60.6% |
| Q1 2014 | $646,000 | -37.6% | 6,200 | -38.0% | 0.46% | +168.6% |
| Q4 2013 | $1,035,000 | – | 10,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |